Cited by 43Obstructive Sleep Apnea ResearchBlood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Effect of eplerenone on the severity of obstructive sleep apnea and arterial stiffness in patients with resistant arterial hypertension

Open access
Krasińska, Beata, Miazga, Angelika, Cofta, Szczepan, Szczepaniak-Chicheł, Ludwina, Trafas, Tomasz, Krasiński, Zbigniew, Pawlaczyk-Gabriel, Katarzyna, Tykarski, Andrzej·2016·Polish Archives of Internal Medicine

Abstract

INTRODUCTION Obstructive sleep apnea (OSA) is considered to be one of the major causes of resistant arterial hypertension (RAH). Apnea episodes cause hypoxia, which triggers the activation of the renin-angiotensin-aldosterone system. This leads to water retention and swelling in the neck region, exacerbating OSA symptoms. It is assumed that the use of eplerenone may reduce the swelling and thus alleviate the severity of OSA. OBJECTIVES We aimed to prospectively assess the impact of eplerenone on the severity of OSA and arterial stiffness in patients with RAH. PATIENTS AND METHODS The study included 31 patients with RAH and OSA. The exclusion criteria were as follows: secondary hypertension, myocardial infarction, stroke 6 months prior to the study, congestive heart failure, chronic kidney failure, alcohol or drug addiction, and active cancer. In all patients, the following tests were performed: blood pressure (BP) measurement (traditionally and using ambulatory BP measuring [ABPM]), applanation tonometry, polysomnography, and the apnea-hypopnea index (AHI) calculation. The tests were done before and after 3 months of eplerenone therapy. Patients received 50 mg of oral eplerenone daily, along with other hypertensive drugs. RESULTS The mean age of participants was 57.76 ±6.16 years. After 3 months of eplerenone therapy, we observed a significant reduction in the AHI, neck circumference, BP, aortic pulse wave, and arterial wall stiffness. There were significant correlations between the AHI and mean BP measured by ABPM and between the AHI and arterial stiffness parameters. CONCLUSIONS Our results provide evidence for the clinical significance of eplerenone, not only as an antihypertensive medication but also as a drug that may reduce the severity of OSA and arterial stiffness in patients with RAH and OSA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.20452/pamw.3410

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The role of aldosterone in promoting obstructive sleep apnea is additionally supported by studies demonstrating that mineralocorticoid receptor antagonists reduce the severity of obstructive sleep apnea in patients with resistant hypertension.

    “The role of aldosterone in promoting OSA is additionally supported by studies demonstrating that mineralocorticoid receptor antagonists reduce the severity of OSA in patients with RH.280–282”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Yumino D, Redolfi S, Ruttanaumpawan P, et al. Nocturnal rostral flu- id shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation. 2010; 121: 1598-1605.
  2. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163: 19-25.

Cited by

Sorted by citations

Authors
Krasińska, B., Miazga, A., Cofta, S., Szczepaniak-Chicheł, L., Trafas, T., Krasiński, Z., Pawlaczyk-Gabriel, K., & Tykarski, A.
Affiliations
Poznan University of Medical Sciences (PL)
Corresponding author
Krasińska, Beata
Venue
Polish Archives of Internal Medicine
Published
2016-05-27
Volume
126
Issue
5
Pages
330-339
ISSN
  • 0032-3772 (ISSN-L)
  • 1897-9483
OpenAlex
W2415752760
Cited by
43
References
22
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 5 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 3
FWCI
5.10
Type
journal article
Language
en
Open access
Locations
  • Polskie Archiwum Medycyny Wewnętrznej (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
eplerenone, obstructive sleep apnea, resistant hypertension, arterial stiffness, apnea-hypopnea index, renin-angiotensin-aldosterone system, neck circumference, aortic pulse wave, antihypertensive therapy
MeSH terms
Eplerenone, Aged, Female, Humans, Hypertension, Male, Middle Aged, Severity of Illness Index, Spironolactone, Sleep Apnea, Obstructive, Vascular Stiffness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review